| Nr | Land | Plaats | Chemo type | Antilichaam middel | Myelo / Non-Myelo ablative | Zuivermethode |
|---|---|---|---|---|---|---|
| 2 | België | Antwerpen | ||||
| 2 | België | Hasselt | ||||
| 3 | Brazilië | Cyclophosphamide | rATG | Non-myelo | in-vivo | |
| 4 | Canada | Ottawa | Busulphan + Cyclophosphamide | rATG | Myelo | ? |
| 5 | Duitsland | Heidelberg | BEAM | rATG | Myelo | in-vivo |
| 6 | Filippijnen | BEAM-like | hATG | ? | ? | |
| 7 | India | Cyclophosphamide | ATG | Non-myelo | ? | |
| 8 | Israël | Jerusalem | BEAM | rATG | Myelo | ? |
| 9 | Italië | Florence | BEAM | rATG | Myelo | in-vivo |
| 10 | Mexico | Monterrey | Cyclophosphamide | Rituximab | Non-myelo | in-vivo |
| 11 | Mexico | Puebla | Cyclophosphamide | Rituximab | Non-myelo | in-vivo |
| 12 | Polen | Katowice | Cyclophosphamide | rATG | Non-myelo | ex-vivo |
| 13 | Rusland | Moskou | Cyclophosphamide | Rituximab | Non-myelo | in-vivo |
| 14 | Singapore | Cyclophosphamide + Fludabarine | none | Non-myelo | ex-vivo | |
| 15 | Spanje | Barcelona | Cyclophosphamide | ATG | Non-myelo | in-vivo |
| 16 | Spanje | Pamplona | BEAM | ATG | Myelo | ? |
| 17 | Spanje | Valencia | Cyclophosphamide | ATG | Non-myelo | in-vivo |
| 18 | UK | London | Cyclophosphamide | rATG | Non-myelo | in-vivo |
| 19 | VS | Chicago | Cyclophosphamide | rATG | Non-myelo | in-vivo |
| 20 | VS | Denver | BEAM | rATG | Non-myelo | in-vivo |
| 21 | VS | Seattle | BEAM | rATG | Non-myelo | in-vivo |
| 22 | Zuid-Afrika | Kaapstad | Busulphan + Cyclophosphamide | ? | Myelo | ? |
| 23 | Zweden | Uppsala | Cyclophosphamide | rATG | Non-myelo | in-vivo |
Bedrijfsgegevens
Deze informatieve wiki-website is onderdeel van Stichting Sterker dan MS.
Stichting Sterker dan MSHazestraat 28
5555 AC Valkenswaard
www.sterkerdanms.nl
info@sterkerdanms.nl
Zakelijke gegevens:
KvK registratie: 70893780
RSIN: 858501016
IBAN: NL68 INGB 00083 14 994
BIC/SWIFT: INGBNL2A